Skip to content
AnalystLens

CTVA · Corteva, Inc.

85 filings

8-K

CTVA 8-K Current Reports

Corteva, Inc. - 85 current reports

Filing record · 2019–202610-K710-Q238-K85

CTVA filed 7 annual reports (10-K), 23 quarterly reports (10-Q) and 85 current reports (8-K) between 2019 and 2026.

  1. Leadership change8-K · Jun ’19Jun ’19
  2. Leadership change8-K · Feb ’21Feb ’21
  3. Restructuring8-K · Aug ’22Aug ’22
  4. FY2025 annual report10-K · Feb ’26Feb ’26
Showing 1-50 of 85 filings
8-K
Other Events

Corteva, Inc. 8-K Report, Corporate Update (Oct 13, 2026)

Corteva, Inc. (CTVA) has disclosed that on October 1, 2026, 15 states and one sovereign filed litigation challenging the company's separation into two independent entities, Corteva and Vylor Inc. This litigation led to a temporary restraining order (TRO) issued by the District Court on October 9, 2026, which temporarily prohibited Corteva and its subsidiary EIDP from disposing of assets outside the ordinary course of business and also restricted both entities from paying dividends or repurchasing shares. However, on October 10, 2026, the District Court granted Corteva's request to stay the TRO pending an emergency motion for a stay of the order pending appeal, filed with the Seventh Circuit Court of Appeals. This stay means the TRO is not currently in effect, and the separation is not impacted. Corteva strongly disputes the claims and is actively defending its position through the ongoing appeal process, emphasizing that it does not intend to pay dividends or repurchase shares while the motion is pending.

Oct 13, 20268-K
Shareholder MattersOther EventsExhibits & Filings

Corteva, Inc. 8-K Report, Rights Modification (Oct 7, 2026)

Corteva (CTVA) and its wholly owned subsidiary EIDP, Inc. disclosed in this 8-K, filed October 7, 2026, that Vylor Inc. completed private exchange offers and consent solicitations for three series of EIDP senior notes, with settlement on October 1, 2026. Holders tendered about $1.44 billion of the $1.60 billion principal across the three series, and the company accepted virtually all tendered notes. Accepted notes were retired and canceled, reducing EIDP's outstanding senior notes in these series to about $161 million. The exchanged notes were replaced with new Vylor-issued notes, so the debt obligation moved to a different issuer, but the filing does not say whether Vylor is a Corteva affiliate, what its relationship to EIDP is, or what it does. The filing also reports that, after receiving the required consents by the August 19, 2026 early tender deadline, EIDP entered into a Fourth Supplemental Indenture with U.S. Bank Trust Company dated August 20, 2026. That indenture amended the base indenture and each series' supplemental indenture. The amendments became operative on October 1, 2026, upon settlement. The 8-K is filed under Item 3.03 (Material Modification to Rights of Security Holders) and Item 8.01 (Other Events), but it does not describe the specific changes to covenants, events of default, or other terms. Investors should review the Fourth Supplemental Indenture (Exhibit 4.1, incorporated by reference from the August 20, 2026 filing) to understand what the holders of the remaining notes gave up. For investors, the key takeaways are the high participation rate, the large reduction in EIDP's public senior debt in these series, and the shift of exchanged obligations to Vylor. The remaining holders of roughly $161 million of notes are now subject to the amended indentures. The filing does not discuss financial impact, earnings effects, or the strategic rationale, so these points should be checked against Corteva's other filings and management commentary.

Oct 7, 20268-K
Leadership Changes

Corteva, Inc. 8-K Report, Executive Changes (Oct 7, 2026)

Corteva, Inc. (CTVA) filed an 8-K on October 7, 2026, primarily detailing significant changes to its Board of Directors and executive officer appointments following its Separation event. Several long-standing directors, including Charles V. Magro, Kerry J. Preete, Marcos M. Lutz, and Karen H. Grimes, have resigned from the Board and its committees. These resignations are stated to be in connection with the Separation and not due to any disagreements with the company's operations. Concurrently, Corteva has appointed Luther ("Luke") Kissam as a new director. Furthermore, the company confirmed previous disclosures regarding key executive appointments effective as of the Separation's Effective Time, including Luke Kissam as Chief Executive Officer, Jeff Rudolph as Chief Financial Officer, Brook Cunningham as Chief Commercial Officer, and Ralph Ford as Chief Integrated Operations Officer. The filing also provides updated committee compositions for the Board of Directors.

Oct 7, 20268-K
Acquisitions & DispositionsMaterial AgreementsExhibits & Filings

Corteva, Inc. 8-K Report, Material Agreement (Oct 5, 2026)

Corteva, Inc. (CTVA) has officially completed the separation of its seed operating segment into a new, independent, publicly traded entity named Vylor Inc. (VYLR). This separation, effective October 1, 2026, was executed through a pro rata distribution of Vylor common stock to Corteva shareholders as of September 24, 2026. Vylor Inc. has begun trading on the New York Stock Exchange under the ticker symbol "VYLR", marking its debut as a standalone company in the market. The completion of this separation is a significant strategic move for Corteva, as it allows the company to focus on its remaining core businesses while Vylor Inc. operates independently within the seed sector. In conjunction with this separation, Corteva and Vylor have entered into a series of critical agreements to govern their ongoing relationship, including matters related to tax, employees, transition services, intellectual property, and seed treatment supply.

Oct 5, 20268-K
Other EventsExhibits & Filings

Corteva, Inc. 8-K Report, Corporate Update (Oct 1, 2026)

On October 1, 2026, Corteva announced the final results of the private exchange offers and consent solicitations that its subsidiary Vylor Inc. ran for three series of senior notes issued by EIDP, Inc. (Corteva's wholly owned subsidiary). The offers expired September 30, 2026. Holders validly tendered $434.8 million of the $500 million 2.300% notes due 2030 (86.97%), $476.2 million of the $500 million 5.125% notes due 2032 (95.24%), and $527.6 million of the $600 million 4.800% notes due 2033 (87.93%). In aggregate, about $1.44 billion of the $1.60 billion outstanding principal was tendered, or roughly 90%. Vylor will issue new Vylor Notes with matching coupons and maturities in exchange for the tendered EIDP Notes. The exchange is tied to Corteva's planned separation into two independent public companies: one holding the current crop protection business and the other holding the seed business, which will be owned by Vylor. All conditions other than completion of the separation were satisfied at expiration. Settlement is expected substantially simultaneously with the separation, on or about October 1, 2026, subject to the remaining conditions. The filing does not confirm that the separation has closed. Tendering holders who acted by the August 19, 2026 early deadline received a small cash payment of roughly $2.67 to $2.90 per $1,000 of principal. Holders who tendered later received $970 of Vylor Notes per $1,000 with no cash. All accepted holders also receive accrued interest. The consent solicitations seek amendments to the EIDP indentures, but the filing does not describe those amendments. For investors, the transaction is primarily a liability-management step that moves debt tied to the seed business to Vylor ahead of the separation. Its economic effect on Corteva is limited, since the cash consideration is small (at most about $4 million in aggregate) and the coupons and maturities are unchanged. The main points to monitor are whether the separation closes on schedule and whether any untendered EIDP Notes remain outstanding after settlement.

Oct 1, 20268-K
Exhibits & Filings

Corteva, Inc. 8-K Report, Exhibit Filing (Oct 1, 2026)

Corteva, Inc. (CTVA) filed this 8-K on October 1, 2026 to furnish carve-out financial statements, unaudited pro forma information, and non-GAAP reconciliations for New Corteva, the Crop Protection business that remains after the completion of the spin-off of its Seed business as Vylor Inc. The filing is primarily informational, but it establishes the standalone financial profile investors will use going forward. For FY2025, New Corteva reported net sales of $7,840 million (up 3.8% from $7,553 million), income from continuing operations after taxes of $669 million (versus a loss of $81 million in 2024), and operating EBITDA of $1,486 million (19.0% margin, per the non-GAAP reconciliation). Pro forma FY2025 figures, which reflect the new capital structure and commercial agreements with Vylor, show net sales of $7,592 million and pro forma operating EBITDA of $1,298 million. The balance sheet and liquidity picture changed materially in 2026. Cash fell from $3,685 million at year-end 2025 to $1,904 million at June 30, 2026, after a discretionary pension contribution of roughly $1.5 billion and an operating cash outflow of $965 million in the first half. Short-term borrowings rose to $3,092 million, largely commercial paper, before the spin-off. Pro forma adjustments show roughly $3.5 billion of cash received from Vylor, the repayment of about $3.0 billion of short-term debt, and the exchange of $1.439 billion of legacy EIDP notes into Vylor obligations. Pro forma pension obligations rise, and the balance sheet remains in place with about $3.1 billion of cash and about $0.9 billion of long-term debt. Investors should weigh the reported strength in 2025 and H1 2026 operating EBITDA (H1 2026 operating EBITDA of $815 million, 21.2% margin, versus $731 million in H1 2025) against significant legacy PFAS and other litigation exposure. The 2026 period includes large accruals, including a $121 million litigation settlement charge, and the filing discloses subsequent-event settlements with New Jersey ($875 million over 25 years, roughly $500 million net present value, with Corteva's share recorded), North Carolina ($455 million across the companies, with Corteva's share about $66 million), and a $1.2 billion-equivalent FTC/multi-district antitrust resolution. Additionally, on October 1, 2026, Indiana and other state attorneys general sought a temporary restraining order against asset transfers, tied to fraudulent conveyance claims. That motion is an important near-term risk for the spin-off structure.

Oct 1, 20268-K
Other Events

Corteva, Inc. 8-K Report, Corporate Update (Oct 1, 2026)

Corteva, Inc. has successfully completed the separation of its seed operating segment into a new, independent publicly traded company named Vylor Inc. This separation was executed via a pro rata distribution of Vylor's common stock to Corteva shareholders as of September 24, 2026. Vylor is expected to begin trading on the New York Stock Exchange under the ticker symbol 'VYLR' on October 1, 2026, marking a significant strategic shift for both entities. This strategic move positions Corteva to focus on its remaining businesses while Vylor emerges as a standalone entity with its own distinct strategic direction and capital allocation priorities. Investors should note this event as a material change in the corporate structure of Corteva, impacting its future revenue streams, profitability, and overall market positioning.

Oct 1, 20268-K
Other Events

Corteva, Inc. 8-K Report, Corporate Update (Oct 1, 2026)

Corteva, Inc. (CTVA) announced via an 8-K filing on October 1, 2026, that the previously announced separation into Corteva and Vylor Inc. is expected to be completed prior to 9:30 a.m., New York City time, on October 1, 2026. This follows a legal challenge from the State of California, which sought to delay the separation. While the Fourth Circuit Court of Appeals initially reversed a lower court's denial of California's motion for a temporary restraining order and preliminary injunction, the matter was remanded. Subsequently, the District Court denied California's motion to enjoin the separation. Corteva's board has waived a condition related to legal restraints, clearing a significant hurdle for the distribution of Vylor shares.

Oct 1, 20268-K
Other EventsExhibits & Filings

Corteva, Inc. 8-K Report, Corporate Update (Sep 30, 2026)

Corteva, Inc. (NYSE: CTVA) filed an 8-K furnishing a press release that extends the expiration date of the private exchange offers and consent solicitations for three series of senior notes issued by its wholly owned subsidiary EIDP, Inc. The expiration moves from 5:00 p.m. NYC time on September 29, 2026 to 5:00 p.m. NYC time on September 30, 2026, and may be extended further. Under the offers, eligible holders can exchange EIDP notes for new notes to be issued by Vylor Inc., a wholly owned Corteva subsidiary. The offers are tied to the planned separation of Corteva into two independent public companies: one for crop protection and one for seed, which Vylor will own. Each exchange offer and consent solicitation is conditioned on completion of that separation, and the separation is not described as completed in this filing. Participation was high. As of 5:00 p.m. on September 29, 2026, holders had validly tendered about $1.44 billion of the $1.60 billion aggregate principal of the three series, or roughly 90%. The 5.125% notes due 2032 had the highest participation at 95.24%, while the 2.300% notes due 2030 (86.97%) and the 4.800% notes due 2033 (87.93%) were somewhat lower. Requisite consents were received, and a supplemental indenture has been executed. The proposed amendments take effect only upon settlement, which is expected on or about the first business day after the expiration date and substantially simultaneously with the separation. Vylor may further extend the dates to keep that sequencing. For investors, the filing is primarily a procedural update, but it signals that the debt restructuring is advancing alongside the separation. Settlement timing depends on closing the separation, so the schedule could shift. The filing contains no new financial results, guidance, or separation terms, and it is not an offer to sell securities. Investors should watch for the separation closing, the settlement announcement, and any further extensions.

Sep 30, 20268-K
Other EventsExhibits & Filings

Corteva, Inc. 8-K Report, Corporate Update (Sep 25, 2026)

Corteva, Inc. (NYSE: CTVA) filed a Form 8-K on September 25, 2026 under Item 8.01 (Other Events), attaching a September 24, 2026 press release announcing that the SEC has declared effective the Form 10 registration statement for Vylor, the company's seed and genetics business being spun off. The filing is informational rather than financial: it contains no earnings, revenue, guidance, or balance sheet data. Its significance lies in confirming that the separation is proceeding on schedule. According to the release, the separation is expected to be completed on October 1, 2026. Corteva stockholders of record as of the close of business on September 24, 2026 will receive one share of Vylor common stock for each share of Corteva common stock held. The distribution is expected before 9:30 a.m. New York time on October 1, and Vylor is authorized to list on the NYSE under the ticker "VYLR," with regular-way trading expected to begin the same day. Corteva has stated there will be no when-issued trading in Vylor and no ex-distribution trading in Corteva prior to the distribution. For investors, the key points are the record date, the distribution ratio, and the timing. The release does not quantify the financial profile of either company post-separation, and the forward-looking statements caution that the separation's objectives, costs, and timing are not guaranteed. Investors should review the Vylor Form 10 for business, strategy, and financial details, and monitor for final distribution and trading confirmation.

Sep 25, 20268-K
Other EventsExhibits & Filings

Corteva, Inc. 8-K Report, Corporate Update (Sep 24, 2026)

Corteva, Inc. (CTVA) filed this 8-K on September 24, 2026 to disclose the private offering of $700 million of 6.000% senior notes due August 15, 2036, issued by EIDP, Inc. (formerly E. I. du Pont de Nemours and Company), Corteva's subsidiary. The notes were sold under Rule 144A and Regulation S, and the proceeds are earmarked for general corporate purposes, including repaying commercial paper. The financing is tied to Corteva's previously announced plan to separate into two independent public companies: a crop protection business housed in EIDP, and a seed business to be owned by Vylor Inc., a wholly owned EIDP subsidiary. The key investor protection is a special mandatory redemption feature. If the separation is not completed, EIDP must redeem the notes at 101% of principal plus accrued interest, and failure to do so would be an event of default. The redemption feature falls away once the separation closes. EIDP also agreed to file a registration statement (an exchange offer or shelf resale registration) within 366 days of the separation's completion, with a 0.25% additional interest step-up if it fails to meet registration deadlines. The filing does not indicate when the separation is expected to close, so timing of the redemption risk remains open. For investors, the filing mainly confirms that the separation is being financed with long-dated, fixed-rate debt at the EIDP level, which refinances short-term commercial paper and shifts term funding to the crop protection entity. The 8-K itself contains no new financial results, guidance, or balance sheet figures, so its significance depends on the separation's execution and the post-spin capital structure of each resulting company.

Sep 24, 20268-K
Regulation FD

Corteva, Inc. 8-K Report, Regulation FD Disclosure (Sep 21, 2026)

Corteva, Inc. (CTVA) announced on September 21, 2026, that its subsidiary, Vylor, Inc. ("Vylor"), has filed Amendment No. 3 to its Registration Statement on Form 10 with the SEC. This filing is a significant step in Corteva's previously announced plan to separate into two independent, publicly traded companies by spinning off its seed operating segment into the new entity, Vylor. The Form 10 filing provides crucial details about Vylor's business operations, strategic direction, and historical financial performance, offering investors a clearer picture of the standalone seed company. This development is pivotal for investors seeking to understand the future structure and value proposition of both Corteva and the new Vylor entity. The detailed information in the Form 10 allows for a more thorough assessment of the potential benefits, risks, and strategic implications of this separation. Investors should carefully review this filing to gauge the investment merits of each resulting company post-separation, considering the inherent uncertainties and risks associated with such a significant corporate restructuring.

Sep 21, 20268-K
Regulation FDOther EventsExhibits & Filings

Corteva, Inc. 8-K Report, Regulation FD Disclosure (Sep 15, 2026)

Corteva, Inc. (NYSE: CTVA) disclosed in this 8-K that its board approved on September 12, 2026 the previously announced separation of the company into two independent, publicly traded companies. The separation will be effected by spinning off its seed operating segment as Vylor Inc. (NYSE: VYLR). Corteva will declare a pro rata dividend of all Vylor common stock to Corteva stockholders of record at the close of business on September 24, 2026, with distribution expected before 9:30 a.m. New York time on October 1, 2026. Each Corteva holder will receive one Vylor share for each Corteva share held, with cash in lieu of fractional shares. The transaction is intended to be tax-free to U.S. federal income tax purposes, except for cash received for fractional shares. Trading mechanics are set out for investors. When-issued Vylor trading (VYLR WI) is expected from September 25 through September 30, 2026, and regular-way Vylor trading is expected to begin October 1, 2026. Corteva will have two markets from September 25 through September 30: a regular-way market (CTVA), where shares carry the entitlement to Vylor shares, and an ex-distribution market (CTVA WI), where they do not. The filing also references Amendment No. 2 to Vylor's Form 10 registration statement, which provides detailed information on Vylor's business, strategy and historical financial results. The filing itself contains no financial results, guidance, or valuation data, so investors should rely on the Form 10 and the Investor Day materials for those details. The completion of the spin-off is subject to customary conditions that Corteva expects to be satisfied before distribution. This filing describes expected timing only. As of the current date (October 21, 2026), the scheduled distribution date has passed, so investors should confirm completion and final trading details through Corteva's and Vylor's subsequent public filings.

Sep 15, 20268-K
Other EventsExhibits & Filings

Corteva, Inc. 8-K Report, Corporate Update (Sep 10, 2026)

Corteva, Inc. (CTVA) announced a significant settlement on September 9, 2026, resolving statewide PFAS claims and specific site-related issues in North Carolina. As part of this agreement, Corteva and its subsidiary EIDP, Inc. will collectively pay approximately $66 million over 15 years. This settlement is a component of a larger collective payment of $455 million by Corteva, EIDP, The Chemours Company, and DuPont de Nemours, Inc. to the State of North Carolina and its subdivisions. Furthermore, Corteva and DuPont will jointly guarantee Chemours' share of the settlement payments and establish a reserve fund of up to $135 million. This settlement also impacts the existing Memorandum of Understanding (MOU) among the parties. The North Carolina settlement payments will be applied against the MOU's $4 billion qualified spend cap, valued at their net present value ($210 million), and will satisfy future escrow contribution obligations, alleviating future cash requirements for these specific obligations.

Sep 10, 20268-K
Other EventsExhibits & Filings

Corteva, Inc. 8-K Report, Corporate Update (Aug 31, 2026)

On August 31, 2026, Corteva (CTVA) disclosed that its subsidiary Vylor Inc. completed a private Rule 144A/Regulation S offering of $1.1 billion in senior unsecured notes, split evenly into $550 million of 5.125% notes due August 15, 2031 and $550 million of 5.625% notes due August 15, 2036. The proceeds are earmarked mainly for a cash distribution to EIDP, Inc., Corteva's wholly owned subsidiary and Vylor's parent, as partial consideration for contributing the seed business to Vylor in connection with the planned separation of Corteva into two independent public companies: a crop protection company and a seed company owned by Vylor. Any excess proceeds will fund fees and expenses tied to the previously disclosed exchange offers for EIDP's 2030, 2032 and 2033 notes, and will support general corporate purposes. The notes carry important protections and conditions. They are guaranteed by EIDP on a senior unsecured basis until the separation closes, at which point EIDP is automatically released. A special mandatory redemption requires Vylor to repurchase the notes at 101% of principal plus accrued interest if the separation is not completed, and failure to do so would be an event of default. Vylor has also agreed to file an exchange offer or shelf registration statement within 366 days of becoming an independent public company, with additional interest of 0.25% per annum if registration defaults occur. For investors, the filing is a financing milestone that signals the separation is advancing, but it is largely a structural and balance-sheet event rather than a change in operating results. The filing does not disclose separation timing, pro forma financials, or the total debt allocation between the two future companies, so investors should look to subsequent filings (such as Form 10 registration and exchange offer documents) for those details.

Aug 31, 20268-K
Other EventsExhibits & Filings

Corteva, Inc. 8-K Report, Corporate Update (Aug 20, 2026)

On August 20, 2026, Corteva, Inc. (NYSE: CTVA) disclosed via Exhibit 99.1 (furnished under Item 8.01) the early tender results and an extension of its private exchange offers and consent solicitations for three series of senior notes issued by its wholly owned subsidiary EIDP, Inc. The exchange offers are being made by Vylor Inc., a wholly owned Corteva subsidiary that will hold the seed business in the planned separation. Holders tendered a majority of each series by the August 19, 2026 early deadline: 86.33% of the 2.300% notes due 2030, 93.69% of the 5.125% notes due 2032, and 87.48% of the 4.800% notes due 2033. The Requisite Consents to strip substantially all restrictive covenants and non-payment events of default from the EIDP base indenture were received, while majority consents for the change-of-control repurchase amendments on each series are not a condition to the exchanges. The expiration date was extended from September 3, 2026 to September 29, 2026. Holders tendering early receive $1,000 of new Vylor notes per $1,000 of old notes plus a cash payment of roughly $2.67 to $2.90 per $1,000, along with accrued interest. Holders tendering after the early deadline receive $970 of Vylor notes per $1,000 and no cash consideration. Settlement is expected substantially simultaneously with the separation, currently targeted for on or about October 1, 2026. The exchanges are conditioned on the separation being completed, so if it does not close, neither the exchanges nor the proposed covenant changes will take effect. For investors, the key issues are the separation timing, the credit profile of the new Vylor notes versus the legacy EIDP notes once covenant protections are removed, and whether the remaining EIDP holders are left with weaker creditor protections. The filing itself is a tender and extension notice and does not include financial results or the separation's financial details, so those must be sourced from Corteva's other SEC filings.

Aug 20, 20268-K
Material AgreementsShareholder MattersExhibits & Filings

Corteva, Inc. 8-K Report, Material Agreement (Aug 20, 2026)

Corteva, Inc. (CTVA) has filed an 8-K detailing material definitive agreements related to its previously announced separation into two independent companies: one for crop protection and one for seeds (to be operated under Vylor Inc.). The key event is the commencement of private offers to exchange and consent solicitations for EIDP's outstanding senior notes. These offers are structured to allow holders of Corteva's existing EIDP Notes (2.300% Senior Notes due 2030, 5.125% Senior Notes due 2032, and 4.800% Senior Notes due 2033) to exchange them for new notes issued by Vylor. A significant development reported is that the necessary consents have been obtained to amend the EIDP Base Indenture and related supplemental indentures. These amendments will eliminate most restrictive covenants and change-of-control repurchase provisions, subject to the successful completion of the separation and the exchange offers. A fourth supplemental indenture has been entered into, which will become effective upon settlement of these transactions, marking a crucial step in restructuring the company's debt in anticipation of the spin-off.

Aug 20, 20268-K
Regulation FD

Corteva, Inc. 8-K Report, Regulation FD Disclosure (Aug 14, 2026)

Corteva, Inc. (CTVA) announced via an 8-K filing on August 14, 2026, that its subsidiary, Vylor, Inc., has filed its first amendment to its Form 10 registration statement. This filing is a critical step in Corteva's previously announced plan to separate its seed business into an independent, publicly traded company. The Form 10 provides investors with comprehensive details regarding Vylor's business operations, strategic direction, and historical financial performance, offering a clearer picture of the prospective standalone entity. This development is of significant interest to Corteva shareholders as it signals progress towards the separation. Investors should review the Vylor Form 10 to understand the distinct value proposition, risks, and opportunities associated with the new seed business entity. The cautionary statement highlights the inherent uncertainties and potential risks associated with such a spin-off, including impacts on personnel, customer relationships, and overall business operations, as well as the possibility that the transaction may not be consummated.

Aug 14, 20268-K
Regulation FDOther EventsExhibits & Filings

Corteva, Inc. 8-K Report, Regulation FD Disclosure (Aug 6, 2026)

Corteva, Inc. (CTVA) filed an 8-K on August 6, 2026 disclosing that its subsidiary Vylor Inc., the entity that will hold the seed business under the planned Separation, has launched private exchange offers and consent solicitations for $1.6 billion of EIDP, Inc. senior notes (2.300% due 2030, 5.125% due 2032, and 4.800% due 2033). Holders who tender by the August 19, 2026 Early Tender Deadline receive an equal principal amount of new Vylor notes plus a cash payment of $2.50 to roughly $5.00 per $1,000 principal, while later tenders receive $970 of Vylor notes per $1,000 with no cash. The offers are conditioned on completion of the Separation, which is currently expected around October 1, 2026, and on receipt of requisite consents to strip substantially all restrictive covenants and most events of default from the EIDP base indenture. The offers are not conditioned on majority consents to remove change-of-control repurchase rights. The filing's Exhibit 99.1 provides the financial framework for Vylor. Management expects a debt-to-EBITDA leverage ratio of roughly 0.8x to 1.1x at December 31, 2026, with a longer-term target of no more than 2.5x for Vylor (and 2.0x for New Corteva). Estimated total borrowings at separation are $5,579 million, against $1,100 million of cash. Pro forma figures for the year ended December 31, 2025 show net sales of $10,067 million and pro forma operating EBITDA of $2,503 million for Vylor, while the pro forma income from continuing operations after management adjustments is $269 million. Pro forma net sales for Q1 2026 were $3,043 million, with operating EBITDA of $979 million, though these figures include illustrative assumptions such as 80% tender participation and forward-looking cost reductions. For investors, the key takeaways are that the separation is advancing on schedule, the debt restructuring is designed to move legacy EIDP notes onto Vylor's balance sheet, and the proposed covenant stripping would significantly reduce bondholder protections for holders who do not tender. Investors should weigh the attractive early-tender economics against the loss of covenant protection for non-participating holders, and should recognize that the Separation remains subject to conditions, the Board's discretion, and the outcome of the consent process.

Aug 6, 20268-K
Earnings & ResultsExhibits & Filings

Corteva, Inc. 8-K Report, Financial Results (Jul 30, 2026)

Corteva (CTVA) reported second-quarter 2026 results on July 30, 2026, showing a mixed but generally solid picture. Net sales for the quarter were $6.38 billion, down 1% year over year (organic sales down 2%), while GAAP income from continuing operations fell 12% to $1.22 billion and GAAP EPS was $1.81. Operating EBITDA, the company's key non-GAAP profitability measure, rose 4% to $2.26 billion, with margin expanding by more than 190 basis points, and Operating EPS increased 5% to $2.30. Seed was flat in the quarter, with price/mix up 3% offset by a 3% volume decline, while Crop Protection sales fell 4% on lower price and volume, though its segment EBITDA rose 2% on cost actions. For the first half of 2026, net sales rose 4% to $11.28 billion (organic +2%), Operating EBITDA grew 10% to $3.70 billion, and Operating EPS rose 14% to $3.80. Management raised full-year 2026 guidance, now calling for Operating EBITDA of $4.1 to $4.3 billion (about 9% growth at the midpoint) and Operating EPS of $3.60 to $3.80. The company also reaffirmed that the planned separation remains on track for an October 1, 2026 spin-off of Vylor, with a $25 million separation-related dis-synergy headwind included in guidance. Investors should weigh the strong margin and earnings-quality improvement against some items that merit attention: GAAP earnings are pressured by separation costs ($131 million in the first half), a $262 million pre-tax significant items charge (including litigation settlements tied to FTC-related lawsuits), and a sharp increase in short-term borrowings to $3.19 billion. Operating cash flow from continuing operations was negative $3.35 billion for the first half, driven largely by a $3.19 billion decline in deferred revenue and $1.14 billion in pension contributions, which is seasonal but worth monitoring.

Jul 30, 20268-K
Leadership ChangesRegulation FDExhibits & Filings

Corteva, Inc. 8-K Report, Executive Changes (Jun 29, 2026)

Corteva, Inc. (NYSE: CTVA) filed an 8-K on June 29, 2026 disclosing board changes tied to its planned separation of its seed business into a new, independent public company, Vylor, Inc. Four current directors (Karen Grimes, Marcos Lutz, Charles Magro, and Kerry Preete) agreed with the Board to resign effective immediately before the spin-off is consummated. The departures are described as unrelated to any disagreement with the company's operations, policies, or practices. Each is expected to join the Vylor board, which signals that the separation is progressing and that leadership is being staffed for both companies. The filing also announced the post-separation boards. Corteva's nine-person board will be chaired by Greg Page, former chairman and CEO of Cargill, and will include Luke Kissam, named future CEO of Corteva, effective at separation. The company positions the remaining Corteva as a pure-play, asset-light crop protection business focused on innovation and operational efficiency. Vylor's seven-person board will be chaired by Karen Grimes and includes Chuck Magro as future CEO. Vylor is described as an advanced seed and genetics company that will expand its licensing business and explore new row crops. The company said at least one additional Vylor board seat remains open. Vylor also made its first public Form 10 registration filing with the SEC, which contains detailed information on its business, strategy, and historical financials. Management reaffirmed that the separation remains on track for the fourth quarter of 2026. Investors should note that the announcement is largely governance and transition-focused, with no new financial results, guidance, or transaction terms disclosed in this 8-K. The Form 10 is the primary source for Vylor's financial profile, and the spin-off still carries execution, timing, and separation-cost risks as described in the forward-looking statements.

Jun 29, 20268-K/A
Financial Events

Corteva, Inc. 8-K/A Report, Exit or Disposal Costs (Jun 12, 2026)

Corteva, Inc. (CTVA) has announced an expanded scope for its multi-year footprint optimization and productivity initiative, referred to as the Crop Protection Operations Strategy Restructuring Program. The company has committed to the next phase of this program, which includes the intended cessation of production activities at its Asturias, Spain site, subject to consultation processes. Additionally, management has revised its previous estimates related to the exit of its Pittsburg, California production activities. These actions are expected to result in an aggregate pre-tax restructuring and asset-related charge of $750 million to $815 million, an increase of $100 million to $115 million from prior estimates. The charges are comprised of severance, asset-related impairments, and costs associated with exiting production and ceasing operations. Cash payments for these charges are projected to be between $400 million and $443 million, with the overall restructuring substantially complete by the end of 2028. Investors should monitor the outcomes of consultation processes and potential adjustments to these estimates.

Jun 12, 20268-K
Earnings & ResultsExhibits & Filings

Corteva, Inc. 8-K Report, Financial Results (May 5, 2026)

Corteva (CTVA) reported first-quarter 2026 results that beat on growth and profitability, with GAAP net sales up 11% to $4.90 billion (7% organic) and GAAP EPS from continuing operations of $1.07. Operating EBITDA rose 21% to $1.44 billion and Operating EPS rose 33% to $1.50. Seed was the main driver, with net sales up 12% (9% organic) and segment operating EBITDA up 23%, while Crop Protection net sales rose 10% (4% organic) and segment operating EBITDA rose 15%. Price/mix was positive in Seed (+3%) but negative in Crop Protection (-2%, driven by Latin America and APAC competition), while volume grew 6% in both segments. Management reaffirmed full-year 2026 guidance of Operating EBITDA of $4.0-$4.2 billion and Operating EPS of $3.45-$3.70, and reiterated plans to repurchase about $500 million of shares in the first half of 2026. The quarter's GAAP results also absorbed $177 million of pre-tax significant items, including an $85 million litigation settlement tied to the Crop Protection loyalty program MDL and $92 million of restructuring charges, plus $52 million of separation costs. Cash flow from operations was negative $2.9 billion, a seasonal working-capital build driven by a $2.8 billion increase in receivables, while cash fell to $1.96 billion from $4.52 billion at year-end. The separation into two companies remains on track for the second half of 2026. Vylor will be the future seed and genetics company, with Luke Kissam named CEO of New Corteva. The one-time separation costs are expected to be about $350 million, net dis-synergies about $100 million, and the company plans a discretionary pension contribution of about $1.5 billion by July 31, 2026. Investors should watch the Form 10 filing, credit agency reviews, and the September 15, 2026 Investor Day for further detail on capital structures.

May 5, 20268-K
Shareholder Matters

Corteva, Inc. 8-K Report, Shareholder Vote Results (May 1, 2026)

Corteva, Inc. (CTVA) filed an 8-K on May 1, 2026, reporting the results of its Annual Meeting of Stockholders held on April 28, 2026. The meeting saw a strong turnout, with 89.16% of outstanding shares represented. Key outcomes include the overwhelming election of all 12 nominated directors to the Board, the advisory approval of executive compensation, and the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026. The advisory vote on the frequency of executive compensation votes also resulted in a strong preference for an annual vote.

May 1, 20268-K
Leadership ChangesRegulation FDExhibits & Filings

Corteva, Inc. 8-K Report, Executive Changes (Apr 14, 2026)

Corteva (CTVA) disclosed on April 14, 2026 the executive leadership structure for the planned fourth-quarter 2026 separation of its seed business ("SpinCo") from its crop protection business ("New Corteva"). Chuck Magro is slated to become CEO of SpinCo at separation, while Luther "Luke" Kissam, former Albemarle chairman, president and CEO, was named CEO of New Corteva. Kissam joins the company June 1, 2026 as CEO of the Crop Protection Business Unit ahead of the spin-off. His employment terms include a $1.2 million base salary, a 150% target short-term incentive, a $3.75 million one-time 2026 equity award, a $7.5 million target LTI beginning in 2027, and relocation assistance capped at $750,000. He must also resign from the DuPont board on or before June 1, 2026. The filing lays out a largely internal succession. Jeff Rudolph, currently Chief Strategy Officer, becomes New Corteva's CFO, and David Johnson moves from CFO to SpinCo CFO. Samuel Eathington becomes SpinCo CTO and Judd O'Connor becomes SpinCo Chief Commercial and Operations Officer. Brook Cunningham and Ralph Ford are named to New Corteva roles. Robert King, the current EVP of the Crop Protection Business Unit, will step into a strategic advisor role on July 1, 2026, remain through year-end 2026, and receive up to a $1 million transition bonus tied to milestones. His role elimination triggers severance eligibility under the company's change-in-control and severance plan. Several leadership positions remain open or unannounced, including New Corteva's chief legal and chief people officers, and both companies plan investor days on September 15, 2026. The filing also notes that the spin-off timing and outcome remain subject to the risks of separation execution and talent retention.

Apr 14, 20268-K
Earnings & ResultsExhibits & Filings

Corteva, Inc. 8-K Report, Financial Results (Feb 3, 2026)

Corteva reported a mixed but improving fourth quarter and full year 2025. Fourth-quarter net sales fell 2% to $3.91 billion (organic sales down 4%), with volume down 5% due largely to seasonal shifts of North American seed and crop protection deliveries into the first quarter of 2026. GAAP results were weak: a loss from continuing operations of $537 million (EPS of $(0.80)), driven by a $610 million pre-tax charge for the Bayer litigation resolution and a $132 million tax valuation allowance on a Brazilian entity. Non-GAAP operating EBITDA fell 15% to $446 million and operating EPS fell 31% to $0.22. Crop Protection was the main drag, with segment EBITDA down 22% on price pressure in Latin America and higher compensation and R&D costs. For the full year, results were stronger. Net sales rose 3% to $17.40 billion (organic sales up 4%), GAAP EPS from continuing operations was $1.75 (up 43%), and operating EPS was $3.34 (up 30%). Seed was the standout, with segment EBITDA up 19% to $2.64 billion and margins up about 340 basis points. Free cash flow reached $2.9 billion, up 69%, and the company returned over $1.5 billion to shareholders. The company guided 2026 operating EBITDA to $4.0-$4.2 billion (about 7% growth at the midpoint) and operating EPS to $3.45-$3.70. The most significant strategic development is the comprehensive resolution of all litigation with Bayer. Management says the agreement accelerates the path to royalty neutrality to 2026, two years early, and expands freedom to operate and out-licensing opportunities in corn, canola, and cotton. Management estimates roughly $1 billion of aggregate earnings upside over the next decade, though the settlement carries a $610 million cash outflow, largely in the first quarter of 2026. The company also reiterated that the planned separation remains on track for the second half of 2026, with several milestones (new CEO, SpinCo branding, Form 10 amendments) expected in the first half.

Feb 3, 20268-K
Earnings & ResultsExhibits & Filings

Corteva, Inc. 8-K Report, Financial Results (Nov 4, 2025)

Corteva (CTVA) reported third-quarter 2025 results that were strong on the top line and a sharp improvement in profitability versus the prior year, and it raised its full-year 2025 guidance. Q3 net sales rose 13% to $2.62 billion (11% organic), driven by a 12% volume increase, with Seed sales up 33% on early Latin American safrinha deliveries and corn gains. Operating EBITDA swung to $49 million from a $(100) million loss a year earlier, and Operating EPS was $(0.23) versus $(0.49). GAAP results remained negative for the quarter, with a loss from continuing operations of $(308) million, or $(0.46) per share, though this was an improvement from the prior-year loss of $(519) million. Year-to-date, net sales were $13.49 billion (+4%, +6% organic), GAAP EPS from continuing operations was $2.54, and Operating EPS was $3.11 (+39%). Management raised 2025 guidance to net sales of $17.7-$17.9 billion, Operating EBITDA of $3.8-$3.9 billion, and Operating EPS of $3.25-$3.35. The company also gave a preliminary 2026 Operating EBITDA midpoint of $4.1 billion, implying roughly 6% growth. Guidance was credited to year-to-date volume gains, controllable cost levers, and growth in new technology, biologicals, and out-licensing. The company expects to repurchase about $1.0 billion of shares in 2025. The most important strategic item is the planned separation into two independent public companies, announced October 1, 2025: "New Corteva," focused on crop protection including biologicals, and "SpinCo," focused on advanced genetics, gene editing, hybrid wheat, and biofuels. The separation is expected in the second half of 2026 and is intended to be tax-free. Investors should note that quality-of-earnings items remain: a $(308) million GAAP Q3 loss, $(0.13) per share of YTD discontinued operations losses, and a seasonal working capital build in receivables and cash flow from operations that was negative YTD.

Nov 4, 20258-K
Earnings & ResultsExhibits & Filings

Corteva, Inc. 8-K Report, Financial Results (Oct 1, 2025)

On October 1, 2025, Corteva (NYSE: CTVA) announced its Board unanimously approved a plan to split the company into two independent, publicly traded companies via a tax-free spin-off. 'New Corteva' will comprise the current Crop Protection business and be chaired by Greg Page, while 'SpinCo' will comprise the Seed business, anchored by the Pioneer® brand, with Chuck Magro becoming its CEO. The transaction is expected to close in the second half of 2026, subject to final Board approval, a favorable tax opinion from counsel, and effectiveness of a Form 10 registration statement. Corteva may abandon or modify the separation at any time until completion. Based on the filing, estimated 2025 net sales are $7.8 billion for New Corteva (44% of company sales) and $9.9 billion for SpinCo (56%). Management reaffirmed full-year 2025 guidance and said its 2027 value framework remains intact. Both companies are expected to target investment-grade credit ratings and tailored capital allocation strategies, with New Corteva emphasizing biologicals and SpinCo emphasizing advanced genetics and out-licensing. The filing is furnished under Item 2.02 rather than filed, and the announcement is accompanied by an investor call at 8:30 a.m. EDT on October 1, 2025. Investors should note that the separation remains conditional and that the filing discloses no financial terms of the split, such as debt allocation, dividends, or separation costs, which are expected to be provided in later disclosures, including the Form 10.

Oct 1, 20258-K
Leadership ChangesRegulation FDExhibits & Filings

Corteva, Inc. 8-K Report, Executive Changes (Aug 26, 2025)

On August 26, 2025, Corteva, Inc. (NYSE: CTVA) disclosed a planned leadership transition in its legal function. Cornel Fuerer, senior vice president and chief legal and public affairs officer, notified the company on August 21, 2025 of his intent to retire as an executive officer effective September 15, 2025. Jennifer A. Johnson, age 50, will become senior vice president and chief legal officer on that same date, joining the executive leadership team. Johnson previously served as executive vice president, general counsel and corporate secretary at International Flavors & Fragrances (IFF) from February 2021 to May 2025, and earlier held legal roles at DuPont, including support for the seed business. The transition is orderly rather than abrupt. Fuerer will retain oversight of public affairs and continue as corporate secretary until the end of 2025, handing those responsibilities to Johnson then. He will remain a strategic advisor to the company until his full retirement sometime in 2026. The filing discloses no family relationships between Johnson and any directors or executive officers, and no related-person transactions requiring disclosure under Item 404(a) of Regulation S-K. For investors, this is a governance and management-continuity event rather than a financial one. The filing contains no financial results, guidance, or compensation details for Johnson, so its direct impact on valuation is likely limited. Investors may watch whether the handover proceeds smoothly, particularly given the legal function's exposure to commercial, intellectual property, and litigation matters in agriculture.

Aug 26, 20258-K
Earnings & ResultsExhibits & Filings

Corteva, Inc. 8-K Report, Financial Results (Aug 6, 2025)

Corteva (CTVA) reported strong second-quarter and first-half 2025 results on August 6, 2025, and raised its full-year 2025 guidance. Q2 net sales rose 6% to $6.46 billion (7% organic), GAAP EPS from continuing operations was $2.02 (up 34%), and Operating EBITDA grew 13% to $2.16 billion, with roughly 215 basis points of margin expansion. Operating EPS was $2.20, up 20%. Growth was led by Crop Protection, where volume rose 11% on new products, fungicides and biologicals, particularly in Latin America, and Seed, where North American corn area and share gains drove a 3% volume increase and 3% price increase. For the first half, net sales rose 3% to $10.87 billion (5% organic), Operating EBITDA rose 14% to $3.35 billion, and Operating EPS rose 22% to $3.33. Management raised full-year 2025 guidance to net sales of $17.6-$17.8 billion, Operating EBITDA of $3.75-$3.85 billion, and Operating EPS of $3.00-$3.20, implying roughly 21% Operating EPS growth at the midpoint. The company also plans to repurchase about $1 billion of shares in 2025 and increased its dividend. Weak spots include Latin America Seed, where sales fell 26% in Q2 amid just-in-time purchasing in Argentina, and Crop Protection pricing, which declined 2% in the first half on competitive pressure in Latin America. Investors should note that the 8-K furnishes these results under Item 2.02 and that the figures are unaudited press-release data. Management also expects roughly $150-$165 million in 2025 restructuring charges tied to the Crop Protection network optimization, and it says it does not expect a material net impact from tariffs under current policies. The filing contains a meaningful amount of non-GAAP adjustment, so GAAP and operating metrics should be considered together.

Aug 6, 20258-K
Earnings & ResultsExhibits & Filings

Corteva, Inc. 8-K Report, Financial Results (May 7, 2025)

Corteva (CTVA) reported first-quarter 2025 results that beat on profitability while sales dipped modestly. Net sales were $4.42 billion, down 2% year over year, but organic sales rose 3% as price (+1%) and volume (+2%) gains offset a 5% currency drag. GAAP EPS from continuing operations rose to $0.97 from $0.53, and Operating EBITDA climbed 15% to $1.19 billion. Operating EPS increased 27% to $1.13, driven by segment improvements: Seed Operating EBITDA rose 13% to $842 million with margin up about 390 basis points, and Crop Protection Operating EBITDA rose 22% to $377 million with margin up about 425 basis points. Management attributed the margin expansion to net cost reductions, productivity, and raw material benefits. Management reaffirmed full-year 2025 guidance: net sales of $17.2 to $17.6 billion, Operating EBITDA of $3.6 to $3.8 billion, and Operating EPS of $2.70 to $2.95 per share, implying roughly 10% growth at the midpoint for EBITDA and EPS. The company still plans about $1 billion in share repurchases in 2025. Management expects high-single-digit volume gains in Crop Protection offset by low-single-digit price headwinds, and says tariffs are not expected to have a material net impact at current policies. Restructuring charges of $150 to $165 million are expected in 2025. Investors should note several watch items. Reported figures in this filing are not GAAP-to-guidance reconciled for forward-looking non-GAAP measures. Balance sheet metrics show accounts receivable rising sharply to $8.29 billion from $5.68 billion at year-end, while cash fell to $2.0 billion and short-term borrowings rose to $2.29 billion, reflecting the seasonal working capital build typical of the first quarter. Operating cash flow from continuing operations was negative $2.1 billion, which is seasonal but worth monitoring. Latin America was the weakest region, with Seed sales down 32% due to reduced Argentina corn area.

May 7, 20258-K
Shareholder Matters

Corteva, Inc. 8-K Report, Shareholder Vote Results (May 6, 2025)

Corteva, Inc. filed an 8-K on May 5, 2025, detailing the results of its Annual Meeting of Stockholders held on April 30, 2025. The meeting saw strong participation, with over 89% of outstanding shares represented. Key outcomes include the election of all 12 director nominees and an advisory vote to approve executive compensation, both of which passed with significant support from shareholders. Additionally, the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2025 was ratified by stockholders. These results indicate shareholder confidence in the current board of directors and management's compensation structure. The overwhelming ratification of the independent auditor suggests satisfaction with the company's financial reporting oversight. Investors can view these outcomes as stable governance and continued trust in the company's auditing process as Corteva moves forward.

May 6, 20258-K
Leadership Changes

Corteva, Inc. 8-K Report, Executive Changes (Feb 19, 2025)

Corteva, Inc. announced a change in its Board of Directors, with Dr. Rebecca Liebert resigning from her position effective February 28, 2025. Dr. Liebert's departure is attributed to her decision to pursue other opportunities and is not due to any disagreements with the company's management or policies. This change will result in a reduction of the Board's size from thirteen to twelve directors.

Feb 19, 20258-K
Earnings & ResultsExhibits & Filings

Corteva, Inc. 8-K Report, Financial Results (Feb 5, 2025)

Corteva's fourth-quarter and full-year 2024 results, furnished under Item 2.02 on February 5, 2025, show a company with a strong finish to a flat year. Q4 net sales rose 7% to $3.98B (organic +13%), driven by a 17% volume gain led by Brazil's Safrinha corn and Latin American crop protection demand. Q4 GAAP results were still a loss from continuing operations of $(50)M, or $(0.08) per share, though this improved sharply from the prior year, while Operating EBITDA rose 36% to $525M and Operating EPS reached $0.32. The Q4 GAAP loss was weighed down by a $120M tax charge tied to a valuation allowance on a Brazilian seed entity and $89M of restructuring charges. For full-year 2024, net sales fell 2% to $16.9B, though organic sales grew 1%. GAAP EPS from continuing operations was $1.22 and Operating EPS was $2.57, down 4% from 2023. Operating EBITDA was roughly flat at $3.4B. Free cash flow improved 40% to $1.7B, supporting $1.5B in cash returned to shareholders. Crop Protection faced continued price pressure, with prices down 5% for the year, while Seed price rose 3%. Full-year 2025 guidance was refined for currency headwinds from a stronger U.S. dollar, with net sales expected at $17.2-17.6B, Operating EBITDA at $3.6-3.8B, and Operating EPS at $2.70-2.95. Management also plans about $1.0B of share repurchases in 2025 and expects $150-165M of pre-tax restructuring charges as crop protection network optimization continues through 2026. Investors should weigh the strong volume momentum and cash generation against persistent Latin American pricing pressure, currency drag, and ongoing restructuring costs.

Feb 5, 20258-K
Earnings & ResultsFinancial EventsExhibits & Filings

Corteva, Inc. 8-K Report, Financial Results (Nov 6, 2024)

Corteva's 8-K furnishes its third-quarter 2024 results, which were weak. Net sales fell 10% year over year to $2.33 billion (down 5% organically), driven by Latin America, where Seed volumes dropped on reduced corn planted area in Argentina and Crop Protection pricing came under pressure. GAAP loss from continuing operations was $519 million ($0.76 per share), and Operating EBITDA was a loss of $100 million versus a gain of $18 million a year earlier. Operating EPS was a loss of $0.49. Year to date, net sales were $12.93 billion (down 4%), GAAP EPS from continuing operations was $1.29, and Operating EPS was $2.24. Seed Operating EBITDA was still up 8% year to date, while Crop Protection Operating EBITDA fell 27%. Management cut full-year 2024 guidance. Net sales are now expected at $17.0 to $17.2 billion, Operating EBITDA at $3.35 to $3.45 billion, and Operating EPS at $2.50 to $2.60, which is about 5% lower at the midpoint. Free cash flow guidance is $1.5 to $2.0 billion, and the company expects to have repurchased about $1 billion of stock in 2024. The company also gave a preliminary 2025 outlook of $17.3 to $17.7 billion in net sales and $3.6 to $4.0 billion in Operating EBITDA, implying roughly 12% Operating EBITDA growth at the midpoint. Item 2.05 discloses an expanded Crop Protection Operations Strategy Restructuring Program, centered on exiting production at the Pittsburg, California site and ceasing operations on select manufacturing lines elsewhere. Total pre-tax restructuring and asset-related charges are now estimated at $650 to $700 million, with $330 to $360 million of cash payments, and the program should be substantially complete by the end of 2026. The Item 2.05 text is dated November 8, 2023, which appears to be a typographical error for 2024. Investors should watch the Investor Day on November 19, 2024 for updated strategy and multi-year financial targets through 2027.

Nov 6, 20248-K
Leadership ChangesRegulation FDExhibits & Filings

Corteva, Inc. 8-K Report, Executive Changes (Oct 15, 2024)

Corteva, Inc. (NYSE: CTVA) filed an 8-K on October 15, 2024 disclosing a leadership transition in its Seed Business Unit. Executive vice president Timothy Glenn notified the company on October 10, 2024 of his intent to retire effective December 1, 2024. He will be succeeded by Judd O'Connor, age 54, who has been the company's commercial president for North America since July 2022 and brings more than 25 years of agriculture industry experience. Glenn will remain as an advisor to the executive leadership team through February 2025, according to the 8-K, to support an orderly handover, while the press release describes his retirement as occurring in the first quarter of 2025. For investors, this is an executive succession event rather than a financial disclosure. The filing contains no financial results, guidance changes, or quantitative impact on earnings, and no compensation terms for either executive were disclosed. The choice of an internal successor with deep North America commercial experience suggests continuity for the seed franchise, which is a core growth and profit driver for Corteva. The announced advisory period and CEO Chuck Magro's endorsement also point to a planned, well-managed transition. The primary items to monitor are execution risk during the handover and whether O'Connor sets any strategic priorities that differ from Glenn's when he takes over. Because the company furnished the press release under Item 7.01 (Regulation FD), the information is not deemed filed for Exchange Act liability purposes. The 8-K also notes there are no family relationships or Item 404(a) related-party transactions involving O'Connor.

Oct 15, 20248-K
Earnings & ResultsLeadership ChangesRegulation FD+1

Corteva, Inc. 8-K Report, Financial Results (Jul 31, 2024)

Corteva reported second-quarter 2024 results on July 31, 2024, showing modest top-line growth but a sharply weaker outlook for Crop Protection. Q2 net sales rose 1% to $6.11 billion (organic sales +2%), GAAP EPS from continuing operations was $1.51 (up 23%), and non-GAAP Operating EBITDA grew 10% to $1.92 billion with Operating EPS of $1.83 (up 14%). Seed was the clear driver: segment Operating EBITDA rose 16% to $1.70 billion on price gains and lower royalty expense, while Crop Protection Operating EBITDA fell 20% to $255 million on competitive pricing pressure and raw material inflation. For the first half, net sales fell 3% and Operating EBITDA fell 1%, with Crop Protection sales down 11%. Management lowered full-year 2024 guidance: net sales of $17.2-$17.5 billion (previously higher), Operating EBITDA of $3.4-$3.6 billion, and Operating EPS of $2.60-$2.80, flat at the midpoint. Free cash flow is expected at $1.5-$2.0 billion, and the company plans about $1.0 billion in share repurchases in 2024. The company also disclosed that CFO David J. Anderson will retire effective September 16, 2024, succeeded by David P. Johnson, formerly CFO of Atkore Inc., whose compensation includes a $725,000 salary, a $450,000 sign-on award, and a $2.8 million one-time equity grant. Investors should weigh the Seed strength and capital return program against Crop Protection pricing pressure, the guidance reduction, and the leadership transition. The filing also indicates Crop Protection restructuring charges of roughly $180-$230 million are expected in 2024, and Q2 significant items totaled $137 million pre-tax. These items are excluded from non-GAAP measures, so investors should review the GAAP figures alongside the adjusted metrics.

Jul 31, 20248-K
Shareholder MattersCorporate Changes

Corteva, Inc. 8-K Report, Bylaw Amendment (May 2, 2024)

Corteva, Inc. (CTVA) filed an 8-K on May 1, 2024, reporting on its Annual Meeting of Stockholders held on April 26, 2024. The most significant event for investors is the approval and subsequent filing of an amendment to the Company's certificate of incorporation. This amendment permits the exculpation of officers, aligning with Delaware General Corporation Law, and became effective on May 1, 2024. While this primarily impacts corporate governance, it signifies management's focus on maintaining strong governance practices. The meeting also saw strong shareholder support for the election of all 13 director nominees and the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2024. Additionally, shareholders approved, by advisory vote, the compensation of the named executive officers, indicating general confidence in the company's executive compensation strategy.

May 2, 20248-K
Earnings & ResultsExhibits & Filings

Corteva, Inc. 8-K Report, Financial Results (May 1, 2024)

Corteva (CTVA) reported first-quarter 2024 results that were largely in line with management's expectations, with GAAP net sales of $4.49 billion (down 8% year over year, or 6% on an organic basis) and GAAP EPS from continuing operations of $0.53 (down 37%). Non-GAAP Operating EBITDA was $1.03 billion (down 16%) and Operating EPS was $0.89 (down 23%). The results were split sharply by segment: Seed performed well, with net sales up 2% and segment operating EBITDA up 15% on price gains of 6% and a roughly 300 basis point margin improvement, while Crop Protection was weak, with net sales down 20%, operating EBITDA down 49%, and segment margin down more than 970 basis points, driven by a 18% volume decline as farmers bought closer to application windows and destocking persisted in EMEA. Management reaffirmed full-year 2024 guidance: net sales of $17.4 to $17.7 billion, Operating EBITDA of $3.5 to $3.7 billion, Operating EPS of $2.70 to $2.90, and Free Cash Flow of $1.5 to $2.0 billion, with about $1.0 billion of planned share repurchases. Management expects Crop Protection growth to return in the second half of 2024, supported by its portfolio, biologicals, and cost actions. Investors should note that the quarter's GAAP results were weighed down by $127 million of pre-tax significant items, including an estimated $54 million Lorsban-related settlement charge and $75 million of restructuring and asset-related charges, and that the company expects $180 to $230 million of 2024 restructuring charges tied to its Crop Protection network optimization. The key question for investors is whether the second-half Crop Protection recovery materializes, since the guidance depends on it. Balance sheet items also merit attention: short-term borrowings rose to $2.1 billion from $198 million at year-end 2023, and cash fell to $1.5 billion, reflecting the seasonal working capital build typical of the first quarter, with operating cash flow from continuing operations of negative $2.6 billion.

May 1, 20248-K
Earnings & ResultsExhibits & Filings

Corteva, Inc. 8-K Report, Financial Results (Jan 31, 2024)

Corteva's 4Q and full-year 2023 earnings release (8-K filed January 31, 2024) showed a mixed year. Full-year net sales fell 1% to $17.23B (organic sales down 3%), but Seed grew 5% on price strength (+13%) while Crop Protection fell 9% (organic -12%) amid strategic product exits, channel destocking, and delayed farmer purchases. Fourth-quarter results were weaker: net sales declined 3% to $3.71B, GAAP loss from continuing operations was $(231)M, and GAAP EPS was $(0.33), largely driven by a $241M restructuring charge tied to the Crop Protection network optimization program. Operating EBITDA was $3.38B for the year (+5%), and Operating EPS was $2.69 (+1%), though GAAP EPS from continuing operations fell 22% to $1.30. Management guided 2024 net sales to $17.4B-$17.7B (about 2% growth at midpoint), Operating EBITDA to $3.5B-$3.7B (about 6% growth), and Operating EPS to $2.70-$2.90. Free cash flow is expected to be $1.5B-$2.0B, and the company plans roughly $1.0B in share repurchases. Management expects the Crop Protection industry to modestly improve as channel inventory rebalances, and it anticipates $180M-$230M in net pre-tax restructuring charges in 2024. For investors, the key takeaways are the strength of pricing and Seed profitability, offset by Crop Protection volume weakness and Latin American headwinds, along with elevated GAAP charges and higher interest expense. Free cash flow improved sharply to $1.2B from $307M, supporting the capital return plans. The 2024 guidance implies modest top-line growth with margin expansion, but execution on the Crop Protection turnaround and restructuring will be critical.

Jan 31, 20248-K
Earnings & ResultsFinancial EventsExhibits & Filings

Corteva, Inc. 8-K Report, Financial Results (Nov 8, 2023)

Corteva's 3Q 2023 results (filed November 8, 2023) showed a top-line and profitability slowdown, though the company held its full-year guidance. Net sales fell 7% to $2.59 billion, with organic sales down 13% as volume dropped 15%, reflecting strategic product exits, Crop Protection destocking, and delayed farmer purchases. Price rose 2%. The GAAP loss from continuing operations was $315 million, or $(0.45) per share, and Operating EBITDA fell 81% to $18 million. Year-to-date, net sales were roughly flat at $13.52 billion, and Operating EBITDA rose 5% to $2.99 billion on price gains and productivity, with Operating EPS up 2% to $2.54. Seed was the bright spot, with year-to-date net sales up 7% on 14% price growth, while Crop Protection net sales fell 10% and its Operating EBITDA fell 18%. The most significant new disclosure is a Crop Protection network restructuring approved November 5, 2023. It includes exiting production at the Pittsburg, California site and ceasing operations on select manufacturing lines elsewhere. Corteva expects pre-tax restructuring and asset-related charges of $410 million to $460 million, including $165 million to $175 million of asset impairments to be recorded in Q4 2023, and expects $90 million to $120 million in future cash payments, mostly completing in 2024. Management targets roughly $100 million in run-rate savings by 2025. The company also affirmed FY2023 guidance of $17.0 to $17.3 billion in net sales, $3.25 to $3.45 billion in Operating EBITDA, and $2.50 to $2.70 in Operating EPS, after revising its Brazil outlook in October. For investors, the key tension is between a weak quarter and a stable full-year outlook that now depends on a strong Q4 and on the restructuring delivering savings. The filing also highlights balance-sheet changes, including short-term borrowings rising to $3.6 billion from $24 million at year-end 2022, and deferred revenue falling sharply from the seasonal pattern. Investors should watch Brazil demand, generic competition in crop chemicals, and the execution and cash cost of the manufacturing consolidation. Results are GAAP-based unless noted, and the Operating metrics are non-GAAP measures that exclude significant items, amortization, and currency effects.

Nov 8, 20238-K
Earnings & ResultsExhibits & Filings

Corteva, Inc. 8-K Report, Financial Results (Oct 27, 2023)

Corteva (NYSE: CTVA) issued a preliminary update on October 27, 2023 (furnished under Item 2.02, not filed) showing weak third-quarter 2023 results and a cut to full-year 2023 guidance. Third-quarter net sales are expected at about $2.6 billion, with a GAAP loss from continuing operations of roughly $315 million (-$0.45 per share), Operating EBITDA of about $18 million (versus $96 million a year earlier), and Operating EPS of about -$0.23. The company attributes the weakness mainly to Brazil: customers are delaying orders and buying just in time, farmer margins are tighter, channel inventory is being destocked in crop chemicals, generic imports are pressuring prices, and fourth-quarter seed deliveries are expected to be lower. Full-year 2023 guidance is now net sales of $17.0-17.3 billion, Operating EBITDA of $3.25-3.45 billion, and Operating EPS of $2.50-2.70. Management reaffirmed its commitment to $750 million of share repurchases in 2023 and said early 2024 outlook views will come on the Q3 earnings call on November 9, 2023, with results released November 8. The release is explicitly preliminary, and management warns that adjustments to the figures could be material after the quarter-end close is finalized. For investors, the key issues are the size of the Brazil-driven shortfall, whether the fourth-quarter slowdown is a timing issue or a structural change in demand and pricing, and what 2024 guidance signals. The Q3 figures include significant items such as Lorsban-related settlement charges of $66 million, restructuring charges, and acquisition costs. Investors should also note that the Q3 Operating EPS loss compares with a loss of $0.12 a year earlier, and the nine-month Operating EPS of $2.54 is roughly in line with the prior year's $2.50.

Oct 27, 20238-K
Earnings & ResultsExhibits & Filings

Corteva, Inc. 8-K Report, Financial Results (Aug 3, 2023)

Corteva reported second-quarter 2023 results on August 3, 2023, with GAAP net sales of $6.05 billion (down 3% year over year; organic sales down 4%) and GAAP EPS from continuing operations of $1.23 (down 10%). Non-GAAP Operating EBITDA rose 2% to $1.75 billion, with roughly 140 basis points of margin improvement, and Operating EPS was $1.60 (down 2%). The quarter was split sharply by segment: Seed grew net sales 8% on 12% price gains and delivered Operating EBITDA up 18%, while Crop Protection net sales fell 23% on a 29% volume decline from strategic product exits and channel destocking, and its Operating EBITDA fell 37%. The more consequential news for investors is guidance. Management lowered full-year 2023 expectations, now calling for net sales of $17.9–18.2 billion (versus prior guidance that was higher), Operating EBITDA of $3.50–3.65 billion, and Operating EPS of $2.75–2.90. Management attributed the reduction to Crop Protection order patterns, which reflect product availability, higher interest rates, and farmers deferring purchases closer to usage. The company still projects 3% sales growth and 11% Operating EBITDA growth at the midpoint, so the cut concerns the trajectory and the Crop Protection recovery rather than a broad deterioration in the Seed business. Balance-sheet and cash-flow details also merit attention. Cash from operations was negative $2.5 billion for the first half, driven by seasonal working-capital build (receivables up $1.9 billion, deferred revenue down $2.8 billion). Total debt rose sharply, with short-term borrowings at $3.0 billion and long-term debt at $2.3 billion, following the Stoller and Symborg acquisitions, which cost about $1.5 billion in the first half. GAAP results also carry a rising non-operating burden, including interest expense that rose from $16 million to $82 million in the quarter, along with ongoing Lorsban and restructuring charges. The company also increased its dividend 7% on an annualized basis, effective in the third quarter.

Aug 3, 20238-K
Other EventsExhibits & Filings

Corteva, Inc. 8-K Report, Corporate Update (May 15, 2023)

Corteva, Inc. (CTVA) announced through its subsidiary, EIDP, Inc., the successful issuance of $1.2 billion in aggregate principal amount of senior notes on May 15, 2023. This offering consisted of $600 million of 4.500% Senior Notes due 2026 and $600 million of 4.800% Senior Notes due 2033. The notes were issued under an existing indenture, supplemented by a second supplemental indenture, and were registered under the Securities Act of 1933. This debt issuance provides Corteva with additional capital, which can be utilized for various corporate purposes, potentially including general corporate operations, strategic investments, or refinancing existing debt. Investors should note the specific coupon rates and maturity dates to assess the company's cost of debt and its long-term financial obligations. The participation of major underwriters like Goldman Sachs, BofA Securities, and SMBC Nikko Securities indicates a standard and well-executed capital markets transaction.

May 15, 20238-K
Earnings & ResultsExhibits & Filings

Corteva, Inc. 8-K Report, Financial Results (May 3, 2023)

Corteva (CTVA) reported first-quarter 2023 results that beat on a non-GAAP basis and raised full-year 2023 guidance. Net sales rose 6% to $4.88 billion (organic sales up 10%, led by EMEA and North America), while GAAP income from continuing operations was $607 million, or $0.84 per diluted share. Non-GAAP Operating EBITDA grew 18% to $1.23 billion and Operating EPS rose 20% to $1.16. Growth was driven mainly by price realization and productivity, which more than offset inflation and currency headwinds. Volumes were weaker, hurt by a shortened Safrinha season, supply constraints in Latin America, and the exit from Russia. Both segments grew. Seed sales increased 7% to $2.70 billion with a 17% price contribution, and Seed Operating EBITDA rose 15% to $652 million. Crop Protection sales increased 5% to $2.19 billion, and its Operating EBITDA rose 23% to $603 million with margin expansion of more than 390 basis points. Latin America and Asia Pacific declined on a reported basis, reflecting weather delays and product exits. Full-year 2023 guidance was raised to include the Biologicals acquisitions of Symborg and Stoller. Management now expects net sales of $18.6 to $18.9 billion, Operating EBITDA of $3.55 to $3.75 billion, and Operating EPS of $2.80 to $3.00. Investors should note that the company's balance sheet shows substantially higher short-term borrowings ($3.79 billion versus $24 million at year-end 2022), and cash fell to $1.65 billion, following the acquisitions and seasonal working capital build. Operating cash flow was negative $3.3 billion, which is typical for the first quarter of this seasonal business and should be weighed against the full-year outlook.

May 3, 20238-K
Shareholder Matters

Corteva, Inc. 8-K Report, Shareholder Vote Results (Apr 27, 2023)

Corteva, Inc. (CTVA) filed an 8-K on April 26, 2023, detailing the results of its Annual Meeting of Stockholders held on April 21, 2023. The primary purpose of the filing was to report the outcomes of shareholder votes on key corporate matters, including the election of directors, an advisory vote on executive compensation, and the ratification of the company's independent auditor. The meeting saw strong participation, with over 87% of outstanding shares represented. Key outcomes include the overwhelmingly approved election of all 13 director nominees, indicating shareholder confidence in the current board's leadership. Additionally, shareholders provided an advisory approval for the compensation of named executive officers. The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2023 was also ratified by a significant majority, reinforcing the company's commitment to financial transparency and independent oversight.

Apr 27, 20238-K
Earnings & ResultsExhibits & Filings

Corteva, Inc. 8-K Report, Financial Results (Feb 1, 2023)

Corteva (NYSE: CTVA) reported fourth-quarter and full-year 2022 results on February 1, 2023, showing strong top-line momentum for the year but a weak quarter on a GAAP basis. Full-year 2022 net sales rose 11% to $17.46 billion (organic sales up 15%), driven by price (up 10% in the year's organic bridge) and volume gains in all regions, with Crop Protection net sales up 17% and Seed up 7%. GAAP income from continuing operations fell 33% to $1.22 billion ($1.66 per diluted share), mainly because of lower non-cash benefits from legacy retirement plans. Operating EBITDA, the company's preferred non-GAAP profit measure, grew 25% to $3.22 billion, and Operating EPS rose 24% to $2.67. Fourth-quarter results were mixed. Net sales grew 10% to $3.83 billion and Operating EBITDA rose 41% to $370 million, but GAAP results turned to a loss from continuing operations of $41 million, or $(0.06) per share, versus income of $155 million a year earlier. The swing reflects restructuring charges tied to the 2022 restructuring actions and the Russia exit, a $33 million AltEn remediation charge, and higher interest expense. Volume declined 1% in the quarter, largely due to lower Pioneer corn deliveries in North America, the Russia exit, and the war in Ukraine. Looking ahead, management guided 2023 net sales of $18.1 billion to $18.4 billion, Operating EBITDA of $3.4 billion to $3.6 billion, and Operating EPS of $2.70 to $2.90. The guidance excludes the pending Stoller and Symborg biologicals acquisitions, which are expected to close in the first half of 2023. The company also expects 2022 restructuring and Russia-related charges of roughly $350 million to $420 million pre-tax, mostly completed in 2023. Investors should weigh the strong pricing and Operating EBITDA momentum against the GAAP earnings volatility, restructuring costs, and the reliance on non-GAAP measures.

Feb 1, 20238-K
Corporate ChangesExhibits & Filings

Corteva, Inc. 8-K Report, Bylaw Amendment (Dec 21, 2022)

Corteva, Inc. (CTVA) filed an 8-K on December 21, 2022, to report on an amendment and restatement of its bylaws, effective December 15, 2022. The primary driver for these changes is to comply with new SEC regulations, specifically Rule 14a-19, which mandates the use of universal proxy cards in director election contests. The updated bylaws introduce specific procedural requirements for stockholders seeking to nominate directors, including stipulations on proxy solicitation and the use of proxy card colors. These amendments are designed to align Corteva's corporate governance with current regulatory standards and streamline certain administrative processes. While the changes are largely technical and driven by compliance, investors should note the increased burden on stockholders initiating proxy contests related to director nominations. Additionally, a procedural change was made to remove the requirement for the company to maintain a detailed list of stockholders for inspection at meetings, aligning with updated Delaware corporate law.

Dec 21, 20228-K
Earnings & ResultsExhibits & Filings

Corteva, Inc. 8-K Report, Financial Results (Nov 3, 2022)

Corteva (CTVA) reported third-quarter 2022 results on November 3, 2022 that showed strong top-line momentum and an improved full-year outlook. Q3 net sales rose 17% to $2.78 billion (22% organic), while GAAP results were weak: loss from continuing operations was $(322) million, or $(0.45) per diluted share, driven by $202 million of pre-tax significant items, including restructuring charges, inventory write-offs and estimated Lorsban settlement expense. Year-to-date net sales grew 12% to $13.63 billion (16% organic), operating EBITDA rose 23% to $2.85 billion, and operating EPS reached $2.50, up 21%. Crop Protection was the standout, with YTD organic sales up 26% and operating EBITDA up 51%, while Seed YTD operating EBITDA grew 4%. Management affirmed 2022 net sales guidance of $17.2 to $17.5 billion and raised the midpoint of operating EBITDA guidance to $3.0 to $3.1 billion, implying roughly 18% growth at the midpoint. Operating EPS guidance is $2.45 to $2.60. The company also announced a definitive agreement to acquire Symborg, a Spanish biologicals business, and an exit from commodity glyphosate, which management expects to reduce 2023 net sales by about $300 million. Total expected 2022 restructuring and other charges, including the Russia exit, are $350 to $420 million. For investors, the key takeaways are the strength of pricing and volume in Crop Protection, the continued push into differentiated products such as Enlist, and a higher earnings outlook. The main offsets are GAAP losses in the quarter, a cash flow from operations deficit of $(2.1) billion YTD driven largely by seasonal receivables and deferred revenue timing, and management's caution about 2023 currency and inflation headwinds.

Nov 3, 20228-K
Earnings & ResultsFinancial EventsExhibits & Filings

Corteva, Inc. 8-K Report, Financial Results (Aug 4, 2022)

Corteva (CTVA) reported second-quarter and first-half 2022 results on August 4, 2022 that beat the prior-year comparison on nearly every line, and management raised full-year 2022 guidance. Q2 net sales rose 11% to $6.25 billion (organic sales +13%, with price up 9% and volume up 4%), and Operating EBITDA grew 18% to $1.72 billion. Operating EPS was $1.64, up 17%. GAAP EPS from continuing operations was $1.37, flat year over year, because GAAP results carried a $155 million pre-tax significant-items charge and smaller non-operating pension and other benefit items than in the prior year. Crop Protection was the standout, with Q2 net sales up 25% and Operating EBITDA up 38%, driven by new products (Enlist herbicides, Onmira fungicide) and strong early demand in Latin America. Seed grew more modestly, with net sales up 4% as price gains offset lower corn acres in North America. The filing's more consequential news is the restructuring program. Following completion of strategic portfolio reviews and a shift to a global business unit model, Corteva will exit non-strategic geographies and product lines and reduce its cost structure. The company now expects 2022 Restructuring Actions (including the Russia exit) to produce total pre-tax charges of $295 to $350 million for the additional actions, on top of the Russia-related charges already recorded. Total restructuring and other charges are expected to be roughly $400 million through Q2 2023, about half of it cash, with more than $200 million in run-rate savings targeted by 2025. Management also raised full-year 2022 net sales guidance to $17.2 to $17.5 billion and Operating EBITDA guidance to $2.95 to $3.10 billion, and it announced a roughly 7% annualized dividend increase effective in Q3. For investors, the key tensions are strong top-line and margin momentum on one side and near-term restructuring costs, cash outflows, and Russia-related exposure on the other. Balance-sheet liquidity has tightened: cash fell to $2.4 billion at June 30, 2022, from $4.5 billion at year-end 2021, largely because of seasonal working capital build, and short-term borrowings rose to $712 million. The company is expected to provide further detail on portfolio outcomes at its September 13, 2022 Investor Day.

Aug 4, 2022
Page 1 of 2